对顺序组合多模式人工肝治疗对与HBV相关的急性至慢性肝衰竭的影响的观察

Xueshi Zhou1,2, Youhan Miu3, Xiaoye Guo2

  • 1Department of Infectious Disease, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215000, China.

PubMed
概括

顺序组合多式人工肝治疗 (SCMALT) 显著改善了与HBV相关的急性至慢性肝衰竭 (HBV-ACLF) 患者的生存率. SCMALT有效降低炎症标志物和MELD得分,提供比传统治疗更好的预后.